Oncolytic Virus Therapy Market Overview
The Oncolytic Virus Therapy Market is rapidly transforming cancer treatment by harnessing genetically engineered viruses to selectively infect and destroy tumor cells. Valued at USD 2.7 billion in 2024, this market is projected to reach USD 9.8 billion by 2035, growing at a robust CAGR of 12.4%. Oncolytic viruses not only directly kill cancer cells but also stimulate the immune system to attack...
0 Comments 0 Shares 8 Views 0 Reviews